Proportion and Factors that Associate with Incidence of Hepatotoxicity in Rheumatoid Arthritis Patients Treated with Methotrexate in RSCM Year 2013-2015
Background Rheumatoid arhtirtis (RA) is a chronic autoimmune disease that mainly attacks joints. It may causes joint deformities which leads to lower quality of life of RA patients. RA is treated with metothrexate (MTX) which inhibiting disease progression. MTX is known for its hepatotoxicity side e...
Main Authors: | Rahma Anindya Prathitasari, Harry Isbagio |
---|---|
Format: | Article |
Language: | English |
Published: |
Indonesia Rheumatology Association
2018-06-01
|
Series: | Indonesian Journal of Rheumatology |
Online Access: | https://journalrheumatology.or.id/index.php/ijr/article/view/92 |
Similar Items
-
METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-10-01) -
METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2016-12-01) -
METHOTREXATE IN RHEUMATOID ARTHRITIS – 2015: NEW FACTS AND IDEAS
by: E. L. Nasonov
Published: (2015-09-01) -
Liver Toxicity in Rheumatoid Arthritis Patients Treated With Methotrexate
by: Vahid Dehestani, et al.
Published: (2015-09-01) -
The Use of Tocilizumab in Combination with Methotrexate in Indonesian Rheumatoid Arthritis Patients (PICTURE INA Study)
by: Bambang Setyohadi, et al.
Published: (2018-06-01)